Recombinant human erythropoietin in the diabetic patient.
Department of Medicine, State University of New York, Brooklyn.
E A
EA
Friedman
B G
BG
Delano
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin